Literature DB >> 10887208

Spontaneous and X-ray-induced chromosomal aberrations in Werner syndrome cells detected by FISH using chromosome-specific painting probes.

M Grigorova1, A S Balajee, A T Natarajan.   

Abstract

Werner syndrome (WS) is a rare autosomal disorder characterized by premature aging exhibiting chromosome instability and predisposition to cancer. Cells derived from WS patients show a variety of constitutionally stable chromosomal aberrations as detected by conventional chromosome banding techniques. We have employed the fluorescence in situ hybridization (FISH) technique using painting probes for 12 different chromosomes to detect stable chromosome exchanges in three WS cell lines and three control cell lines. WS cell lines showed increased frequencies of both stable and unstable chromosome aberrations detected by FISH and Giemsa staining, respectively. One WS lymphoblastoid cell line (KO375) had a 5/12 translocation in all the cells and approximately 60% of the cells had an additional translocated chromosome 12. A high frequency of aneuploid cells was found in all the WS cell lines studied. Though WS cells are known to be chromosomally unstable, unlike other chromosome instability syndromes they are not sensitive to mutagenic agents. We studied the frequencies of X-ray-induced chromosomal aberrations in two WS cell lines and found an approximately 60% increase in the frequencies of fragments and no consistent increase in the frequencies of exchanges.

Entities:  

Mesh:

Year:  2000        PMID: 10887208     DOI: 10.1093/mutage/15.4.303

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  11 in total

1.  Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.

Authors:  Yongli Bai; John P Murnane
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

2.  Clinical utility gene card for: Werner syndrome.

Authors:  Fuki M Hisama; Christian Kubisch; George M Martin; Junko Oshima
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

3.  Pancreatic Adenocarcinoma Associated With Werner's Syndrome (Adult-Onset Progeria).

Authors:  Stephen G Chun; Nelson S Yee; John M Holland; Ralph V Shohet; Melvin P Palalay; Peter K Bryant-Greenwood
Journal:  Gastrointest Cancer Res       Date:  2011-01

Review 4.  The Werner's Syndrome RecQ helicase/exonuclease at the nexus of cancer and aging.

Authors:  Stephen G Chun; David S Shaeffer; Peter K Bryant-Greenwood
Journal:  Hawaii Med J       Date:  2011-03

5.  Clinical utility gene card for: Werner Syndrome--Update 2014.

Authors:  Fuki M Hisama; Christian Kubisch; George M Martin; Junko Oshima
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

6.  Identification of a coiled coil in werner syndrome protein that facilitates multimerization and promotes exonuclease processivity.

Authors:  J Jefferson P Perry; Aroumougame Asaithamby; Adam Barnebey; Foad Kiamanesch; David J Chen; Seungil Han; John A Tainer; Steven M Yannone
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

7.  Ku heterodimer binds to both ends of the Werner protein and functional interaction occurs at the Werner N-terminus.

Authors:  Parimal Karmakar; Carey M Snowden; Dale A Ramsden; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

Review 8.  Roles of Werner syndrome protein in protection of genome integrity.

Authors:  Marie L Rossi; Avik K Ghosh; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2010-01-13

Review 9.  Telomeres, chromosome instability and cancer.

Authors:  Susan M Bailey; John P Murnane
Journal:  Nucleic Acids Res       Date:  2006-05-08       Impact factor: 16.971

10.  Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway.

Authors:  Annapaola Franchitto; Livia Maria Pirzio; Ennio Prosperi; Orazio Sapora; Margherita Bignami; Pietro Pichierri
Journal:  J Cell Biol       Date:  2008-10-13       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.